AnTolRx's Series A Round

AnTolRx raised a round of funding on July 12, 2016.

AnTolRx is approaching the treatment of autoimmune diseases differently–through the development of novel nanoparticle-based therapies to promote antigen-specific immune tolerance. Standard therapies…

Articles about AnTolRx's Series A Round: